🚀 Gate Square Creator Certification Incentive Program Is Live!
Join Gate Square and share over $10,000 in monthly creator rewards!
Whether you’re an active Gate Square creator or an established voice on another platform, consistent quality content can earn you token rewards, exclusive Gate merch, and massive traffic exposure!
✅ Eligibility:
You can apply if you meet any of the following:
1️⃣ Verified creator on another platform
2️⃣ At least 1,000 followers on a single platform (no combined total)
3️⃣ Gate Square certified creator meeting follower and engagement criteria
Click to apply now 👉
Lilac CEO: It is expected that Lilac's new weight loss drug will be approved in early 2026
On January 13th, Jinshi Data reported that Eli Lilly CEO Dave Ricks stated that the company expects its experimental weight-loss drug to be approved as early as the beginning of 2026. Dave Ricks said in an interview that Lilly expects data on the drug, called orforglipron, to be released before mid-2025. He also said that the drug is more convenient for patients and easier to produce on a large scale.